Daiken Biomedical (7780) Stock Overview
Engages in the research and development of healthy food products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
7780 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Daiken Biomedical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$296.50 |
| 52 Week High | NT$351.00 |
| 52 Week Low | NT$81.00 |
| Beta | 0 |
| 1 Month Change | 71.39% |
| 3 Month Change | 92.53% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 66.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7780 | TW Personal Products | TW Market | |
|---|---|---|---|
| 7D | -14.7% | 0.6% | 3.1% |
| 1Y | n/a | -26.7% | 3.3% |
Return vs Industry: Insufficient data to determine how 7780 performed against the TW Personal Products industry.
Return vs Market: Insufficient data to determine how 7780 performed against the TW Market.
Price Volatility
| 7780 volatility | |
|---|---|
| 7780 Average Weekly Movement | 10.8% |
| Personal Products Industry Average Movement | 3.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.5% |
Stable Share Price: 7780's share price has been volatile over the past 3 months compared to the TW market.
Volatility Over Time: 7780's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 20 | n/a | certifications.nutrasource.ca/certified-products/brand?id=DABI |
Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd.
Daiken Biomedical Co., Ltd. Fundamentals Summary
| 7780 fundamental statistics | |
|---|---|
| Market cap | NT$17.79b |
| Earnings (TTM) | NT$242.62m |
| Revenue (TTM) | NT$1.46b |
Is 7780 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7780 income statement (TTM) | |
|---|---|
| Revenue | NT$1.46b |
| Cost of Revenue | NT$505.79m |
| Gross Profit | NT$950.42m |
| Other Expenses | NT$707.79m |
| Earnings | NT$242.62m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.04 |
| Gross Margin | 65.27% |
| Net Profit Margin | 16.66% |
| Debt/Equity Ratio | 0% |
How did 7780 perform over the long term?
See historical performance and comparisonDividends
Does 7780 pay a reliable dividends?
See 7780 dividend history and benchmarks| Daiken Biomedical dividend dates | |
|---|---|
| Ex Dividend Date | Jul 22 2025 |
| Dividend Pay Date | Aug 15 2025 |
| Days until Ex dividend | 1 day |
| Days until Dividend pay date | 23 days |
Does 7780 pay a reliable dividends?
See 7780 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/22 21:45 |
| End of Day Share Price | 2025/07/22 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Daiken Biomedical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.